linkedin_logo_300x300.png
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Farfetch Limited (FTCH) Investors and Encourages Investors to Contact the Firm Before December 19, 2023
08 nov. 2023 11h53 HE | Kirby McInerney LLP
NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Maryland on behalf...
linkedin_logo_300x300.png
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of CS Disco, Inc. (LAW) Investors and Encourages Investors to Contact the Firm Before November 20, 2023
08 nov. 2023 11h28 HE | Kirby McInerney LLP
NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York...
johnson fistel.jpg
Amplitude Investigation Alert: Shareholders Are Encouraged to Contact Johnson Fistel for Their Options
07 nov. 2023 15h05 HE | Johnson Fistel, LLP
SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Amplitude, Inc. (NASDAQ: AMPL), any of its executive...
Compass-logo-RGB-outlines.png
Compass Therapeutics to Participate in Upcoming Investor Events
07 nov. 2023 08h00 HE | Compass Therapeutics
BOSTON, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...
biosig_rgb.png
BioSig Appoints Global MedTech Leader Fred Hrkac as New Executive VP
07 nov. 2023 08h00 HE | BioSig Technologies, Inc.
Westport, CT, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Westport, CT, November 7, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company...
BES_Mark.jpg
VIRTU ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Virtu Financial, Inc. and Encourages Investors to Contact the Firm
06 nov. 2023 21h00 HE | Bragar Eagel & Squire
NEW YORK, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
BES_Mark.jpg
SUNPOWER ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against SunPower Corporation and Encourages Investors to Contact the Firm
06 nov. 2023 21h00 HE | Bragar Eagel & Squire
NEW YORK, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
BES_Mark.jpg
ADOBE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Adobe Inc. and Encourages Investors to Contact the Firm
06 nov. 2023 21h00 HE | Bragar Eagel & Squire
NEW YORK, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
maxcyte logo new.jpg
MaxCyte to Participate in Two Upcoming Investor Conferences
06 nov. 2023 16h05 HE | MaxCyte, Inc.
MaxCyte to Participate in Two Upcoming Investor Conferences Rockville, MD, November 6, 2023 — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling...
BES_Mark.jpg
ADAPTHEALTH ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against AdaptHealth Corp. and Encourages Investors to Contact the Firm
05 nov. 2023 21h00 HE | Bragar Eagel & Squire
NEW YORK, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...